Company intelligence / Profile preview

HASS Bio

Hwaseong-si, Gyeonggi-do, South Koreahassbio.com ↗
Ownership
Private
Development stage
Commercial
01

Overview

HASS Bio is an active South Korean manufacturer specializing in advanced dental materials, particularly lithium disilicate and glass ceramic products. Its flagship Amber Mill line is FDA-approved and CE-certified, with global distribution. The company continues to innovate with new products such as Amber Mill Direct and the upcoming Amber Mill Abut-crown for one-day implant crowns[1][2][3][5].

Therapeutic areas
Other
Modalities
DeviceBiologic
Industry
Implantable Medical Devices
02

Partnerships

IMES-iCOREPritidenta

Beyond the preview

Go deeper on HASS Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HASS Bio.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call